Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

432 Press Releases
DateTitleCompany
10 Oct 17 FDA grants Priority Review to Gilotrif® for uncommon EGFR mutations in advanced NSCLC Boehringer Ingelheim Pharmaceuticals,
Published by
PR Newswire
19 Sep 17 New Documentary Film Shines Light on Physical and Emotional Impact of COPD Boehringer Ingelheim Pharmaceuticals, Inc.,
Published by
PR Newswire
18 Sep 17 CHMP positive opinion to include RE-CIRCUIT® data for atrial fibrillation patients undergoing catheter ablation in Pradaxa® Summary of Product Characteristics Boehringer Ingelheim GmbH,
Published by
Business Wire
17 Sep 17 Boehringer Ingelheim receives positive CHMP opinion for adalimumab biosimilar CYLTEZO® Boehringer Ingelheim ,
Published by
PharmiWeb.com
15 Sep 17 Boehringer Ingelheim receives positive CHMP opinion for adalimumab biosimilar CYLTEZO® Boehringer Ingelheim,
Published by
Business Wire
31 Aug 17 Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for CyltezoTM (adalimumab-adbm), a biosimilar to Humira®, for the treatment of multiple chronic inflammatory diseases Boehringer Ingelheim ,
Published by
PharmiWeb.com
27 Aug 17 Pradaxa® (dabigatran etexilate) dual therapy showed lower rates of major bleeding versus triple therapy with warfarin in atrial fibrillation patients undergoing stent placement Boehringer Ingelheim GmbH,
Published by
Business Wire
19 Aug 17 Boehringer Ingelheim anuncia resultados positivos em todas as unidades de negócios Boehringer Ingelheim ,
Published by
PharmiWeb.com
27 Jul 17 Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA® Boehringer Ingelheim,
Published by
Business Wire
24 Jul 17 Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility Boehringer Ingelheim,
Published by
PharmiWeb.com
14 Jun 17 Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA® Boehringer Ingelheim,
Published by
Business Wire
24 May 17 New Analyses Show SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Improves Breathing for People with Asthma Regardless of BMI or Allergic Status Boehringer Ingelheim ,
Published by
PharmiWeb.com
24 May 17 IPF patients treated with Ofev® (nintedanib) versus placebo were twice as likely to have improved or stable lung function Boehringer Ingelheim ,
Published by
PharmiWeb.com
24 May 17 IPF patients treated with Ofev® (nintedanib) versus placebo were twice as likely to have improved or stable lung function Boehringer Ingelheim Pharmaceuticals,
Published by
PR Newswire
23 May 17 ATS 2017 Spiriva® Respimat® improves breathing for people with asthma regardless of BMI or allergic status Boehringer Ingelheim,
Published by
Business Wire
16 May 17 Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University Boehringer Ingelheim,
Published by
Business Wire
16 May 17 Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China Boehringer Ingelheim,
Published by
Business Wire
05 Apr 17 Boehringer Ingelheim: A New World Leader in Animal Health Boehringer Ingelheim,
Published by
Business Wire
27 Feb 17 Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin Boehringer Ingelheim ,
Published by
PharmiWeb.com
21 Mar 17 Uninterrupted Pradaxa® (dabigatran etexilate mesylate) Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation Boehringer Ingelheim Pharmaceuticals,
Published by
PharmiWeb.com
30 Mar 17 Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries Boehringer Ingelheim,
Published by
PR Newswire
20 Mar 17 Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases Boehringer Ingelheim,
Published by
Business Wire
20 Mar 17 Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation Boehringer Ingelheim,
Published by
Business Wire
15 Feb 17 Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments Boehringer Ingelheim,
Published by
Business Wire
21 Mar 17 Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases Boehringer Ingelheim ,
Published by
PharmiWeb.com
18 Jan 17 Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review Boehringer Ingelheim,
Published by
PR Newswire
30 Mar 17 Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries Boehringer Ingelheim,
Published by
PharmiWeb.com
16 Feb 17 US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment of Asthma in Children Boehringer Ingelheim,
Published by
Business Wire
28 Mar 17 Yankees Baseball Legend Bernie Williams Raises Awareness of Devastating Lung Disease - IPF - in Honor of his Dad Boehringer Ingelheim,
Published by
PR Newswire
02 Mar 17 Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers Boehringer Ingelheim,
Published by
Business Wire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.